Description
Neratinib, marketed under the brand name NERLYNX, It is an prescription medication that has been approved neratinib (NERLYNX) for two different uses at different times:
Early-stage HER2-positive breast cancer
On July 17, 2017, the FDA approved neratinib for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer. The approval was based on the ExteNET trial, a randomized, double-blind, placebo-controlled trial.
Metastatic HER2-positive breast cancer
On February 25, 2020, the FDA approved neratinib in combination with capecitabine for adult patients with advanced or metastatic HER2-positive breast cancer.
What is NERLYNX (Neratinib) ?
NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.
How to order approved “NERLYNX (Neratinib) for tablets” Medicine?
NERLYNX (Neratinib) Tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing NERLYNX and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
